Investing Guru Jim Simons Rolls Out the Red Carpet for Valeant Pharmaceuticals, Cuts Opko Health

Jim Simons, the founder of one of the world’s most successful hedge funds, is splashing out on controversial healthcare stock Valeant Pharmaceuticals (NYSE:VRX). However,┬áthis fund guru is displaying a more cautious attitude towards Opko Health (NASDAQ:OPK). Will these moves take his $85 billion fund to new heights?

Story Continues

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts